Evercore ISI Issues Positive Forecast for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A - Get Free Report) had its price target raised by equities research analysts at Evercore ISI from $125.00 to $130.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an "in-line" rating on the medical research company's stock. Evercore ISI's price objective would suggest a potential upside of 9.05% from the company's previous close.

Other equities research analysts also recently issued reports about the company. Leerink Partners lifted their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Friday, May 30th. UBS Group decreased their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a report on Thursday, May 29th. TD Cowen boosted their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Robert W. Baird decreased their price objective on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a report on Thursday, May 22nd. Finally, Jefferies Financial Group decreased their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a report on Monday, April 21st. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $119.21 on Tuesday. The firm has a market cap of $33.86 billion, a P/E ratio of 29.43, a P/E/G ratio of 3.68 and a beta of 1.23. The stock's 50 day moving average is $114.04 and its 200 day moving average is $123.03. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. Agilent Technologies has a one year low of $96.43 and a one year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm's revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.22 earnings per share. As a group, research analysts expect that Agilent Technologies will post 5.58 EPS for the current year.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of A. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after purchasing an additional 270 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in Agilent Technologies by 16.5% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 7,069 shares of the medical research company's stock worth $950,000 after purchasing an additional 1,003 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in Agilent Technologies during the 4th quarter worth about $26,066,000. Raymond James Financial Inc. purchased a new stake in Agilent Technologies during the 4th quarter worth about $48,172,000. Finally, PNC Financial Services Group Inc. lifted its holdings in Agilent Technologies by 11.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 184,715 shares of the medical research company's stock worth $24,815,000 after purchasing an additional 18,474 shares in the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.